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Remote ischemic conditioning (RIC) represents a novel treatment strategy for limiting myocardial IRI by applying intermittent, sublethal episodes of ischemia and reperfusion to an organ or tissue distant from the heart. Experiments in a canine model by Przyklenk et al first demonstrated that brief ischemic episodes (4 times for 5 min followed by 5 min of reperfusion) of the left circumflex coronary artery significantly reduced myocardial infarct size following sustained occlusion of the left anterior descending coronary artery, that is, remote intracardiac conditioning. 1 Our laboratory went on to demonstrate that a 15-min period of small intestine or renal ischemia was also capable of limiting infarct size, that is, remote inter-organ conditioning. 2 The subsequent discovery that transient ischemia and reperfusion of the limb could also elicit RIC facilitated the Remote Conditioning in PCI and CABG translation of this endogenous cardioprotective phenomenon into the clinical arena. 3 Indeed, there is now clinical evidence suggesting that this remarkable form of protection can be achieved by a simple procedure such as inflation and deflation of a blood pressure cuff around the arm. 4 Although several clinical trials examining RIC in the setting of PCI and CABG have shown reductions in myocardial injury, not all trials have been able to observe a protective effect of RIC. 5-7 Accordingly, we sought to clarify the role of RIC in patients undergoing PCI or CABG and carried out a meta-analysis of randomized clinical trials (RCT) to determine the effects of RIC in these settings. We also assessed whether these effects differed in the presence of (potential) confounders or medical therapies.
Methods

Search Strategy and Eligibility Criteria
A systematic review of the literature was performed in accordance with the PRISMA statement. 8 We searched MEDLINE and EMBASE from inception until February 2012 for relevant studies using the search term 'remote preconditioning', in combination with 'ischemic'. Furthermore, we searched the Clinical Trials Registry (clinicaltrials.gov), and the Current Controlled Trials Registry (controlled-trials.com) for unpublished studies, and the Web for relevant abstracts or presentations from major cardiology and cardiothoracic surgery meetings. In addition, we examined the reference lists and related links of retrieved articles in PubMed to detect studies potentially eligible for inclusion. We included studies if they were randomized trials that compared RIC (defined as remote ischemic pre-, per-or postconditioning) with controls in patients undergoing PCI (elective or primary) or CABG surgery (elective or emergency), and provided data on biomarkers of myocardial injury defined as creatine kinase isoform-MB (CK-MB), troponin T (TnT) or troponin I (TnI).
Data Extraction
Two reviewers (T.Y., O.C.M.), working independently, scanned all abstracts and obtained the full-text reports of records that indicated or suggested that the study was an RCT evaluating RIC in patients undergoing PCI or CABG. After obtaining full reports of the candidate trials, the 2 reviewers independently assessed eligibility from full-text articles. From each study the same 2 investigators separately extracted information on trial characteristics, patient data, and outcome measures using a standardized protocol and reporting document. If insufficient information was available in the article, correspondence authors were contacted for additional information. Disagreements were resolved prior to final analysis.
Statistical Analysis
For continuous data (mean CK-MB, TnT and TnI) Hedges g statistic was used for the calculation of standardized mean differences (SMD). The SMDs were combined using inverse variance weights in the fixed effects model and the DerSimonian and Laird method in the random effects model. 9 Conclusions were drawn based on the results of the random effects calculations because these provide the most conservative estimates of effect size. For continuous variables reported as median ± interquartile range (IQR), the mean and SD were estimated using the median and the estimator SD=IQR/1.35. 10 When variances were reported as standard errors of the mean (SEM), the formula SD=SEM* (sample size) was used to calculate the SDs and SD=range/4 when reported as 5 th and 95 th percentiles. Heterogeneity between trials was examined using the Cochran's Q statistic and the I 2 statistic. 11 I 2 , which ranges from 0% to 100%, describes the proportion of variation in treatment effect estimates that is due to true variation rather than sampling error. A value of 0% indicates no observed heterogeneity, and values of 25%, 50% and 75% indicate low, moderate, and high, respectively. Sensitivity analysis was used to investigate the influence of each study on the overall CABG estimate by calculating a pooled SMD omitting each estimate one at a time. Publication bias and its implications for the present results were assessed by visual examination of funnel plot asymmetry and using Duval and Tweedie's trim-and-fill method and quantified by the Egger regression test. 12, 13 All comparisons were 2-sided and P<0.05 was considered statistically significant. Table 2 continued the next page.) Data given as n (%), mean ± SD or median (upper, lower quartile). a Characteristics presented of isoflurane + RIPC group. Patients allocated into 4 groups receiving either isoflurane or propofol anesthesia with or without RIPC. Wagner et al 21 presented data as mean with 5 th and 95 th percentiles. † Data for cholesterol-lowering drug. ‡ L-RIPC/control/tramadol. # Biomarkers measured in individual studies and used in current meta-analysis. § Data obtained from correspondence author. 3VD, triple-vessel disease; ACS, acute coronary syndrome; AMI, acute myocardial infarction; ASA, acetylsalicylic acid; AVR, aortic valve replacement; BC, blood cardioplegia; CBC, cold-blood cardioplegia; CCC, cold-crystalloid cardioplegia; CK-MB, creatine kinase isoform-MB; CPB, cardiopulmonary bypass; ICCF, intermittent cross-clamp fibrillation; L-RIPC, late phase remote ischemic preconditioning; LV, left ventricular; LVEF, LV ejection fraction; NA, not admissible; NYHA, New York Heart Association; RIC, remote ischemic conditioning; RIPoC, remote ischemic postconditioning; WBC, warm-blood cardioplegia. Other abbreviations as in Table 1 . YETGIN T et al.
Results
The flow diagram of study selection is given in Figure 1 . The literature search initially produced 744 articles. After screening the title and abstract, 219 articles were of potential interest. Application of the eligibility criteria led to the inclusion of 4 articles on PCI 5,14-16 and 13 on CABG. 4,6,7,17-26 Details of the included trials are listed in Table 1 for PCI and Table 2 for CABG. Of the 2 correspondence authors contacted to obtain additional information on anesthetic regimen, 17,20 1 responded and supplied data. 17 
PCI
Four studies involving 557 patients were included in the analysis (283 randomized to RIC and 274 to control). 5,14-16 Procedural characteristics as well as measured biomarkers for myo-
Characteristic
Thielmann et al 19 Ali et al 20 Wagner et al 21 Target Figure 2 ). The I 2 of 83% (Q-statistic: P=0.0006) indicated high heterogeneity. Omitting the only study that used a bilateral stimulus of RIC (instead of the mainly used unilateral stimulus) from analysis decreased the heterogeneity (I 2 =67%, P=0.05), and changed the pooled SMD in favor of RIC (-0.43, 95% CI: -0.76 to -0.10, P=0.01) in the random effects model ( Figure 3A) . 5 Heterogeneity was nullified when restricting the analysis to the primary PCI studies (I 2 =0%, P=0.62), producing a pooled SMD of -0.61 (95% CI: -0.84 to -0.38, P<0.0001), significantly in favor of RIC compared to control (Figure 3B) . 15, 16 In contrast, high heterogeneity was observed in the analysis of the elective PCI studies (I 2 =83%, P=0.01), and a pooled SMD of 0.21 (95% CI: -0.63 to 1.06) was produced using the random effects model. 5, 14 There was no evidence of publication bias for the overall analysis (P=0.38).
CABG
Thirteen studies involving 891 patients were included in the analysis (440 randomized to RIC and 451 to control). 4,6,7,17-26 Surgical characteristics as well as measured biomarkers for myocardial injury are listed in Table 2 .
Meta-analysis indicated a reduction in biomarker levels of myocardial injury in patients receiving RIC compared with controls (random effects model: SMD -0.34, 95% CI: -0.59 to -0.08, P=0.009; Figure 2 ), but moderate heterogeneity was observed (I 2 =69%, Q-statistic: P<0.0001). Omitting the 4 studies using another protocol than the mainly used 3×5-min remote conditioning protocol from analysis, barely affected the heterogeneity (I 2 =68%, P=0.0009), and changed the pooled SMD in favor of RIC (-0.46, 95% CI: -0.76 to -0.16) in the Characteristic a Kottenberg et al 24 Lucchinetti et al 25 Hong et al 26 Target Figure 4B ). 6,7,17,20,21, 23 Sensitivity analysis showed that the omission of each study one at a time did not appreciably change the pooled SMD, and the estimates in each case were within the CI of the pooled estimate ( Figure 5) . The trim-and-fill method imputed missing studies and recalculated the pooled estimate. The imputed Figure 5 . Sensitivity analysis conducted for meta-analysis on the effect of remote ischemic conditioning in coronary artery bypass grafting (CABG). a Isoflurane anesthesia with or without remote ischemic preconditioning; b propofol anesthesia with or without remote ischemic preconditioning. Pooled standardized mean differences (SMDs) and 95% confidence intervals (CIs) were calculated by omitting each study in turn. Boxes, recalculated SMDs; horizontal lines, 95% CIs; outer vertical red lines, upper and lower limit of the 95% CI of the original overall analysis; middle red line, original overall SMD. Figure 6 . Funnel plot of precision for assessing publication bias and its potential impact in coronary artery bypass grafting (CABG). a Kottenberg et al allocated patients into 4 groups receiving either isoflurane or propofol anesthesia with or without remote ischemic preconditioning and presented data separately. 24 The effect sizes of the CABG studies are plotted against their precision, which is the inverse of standard error. Black boxes, original studies relating remote ischemic conditioning to biomarkers of myocardial injury; black diamond, standardized mean difference (SMD) and 95% confidence interval (95% CI) for the metaanalysis. To check for publication bias, the trim-and-fill method imputes ('fills') the theoretically missing studies (white boxes) and then recomputes the pooled effect (white diamond). There was no significant difference between the recomputed effects and the effects derived from the original studies, suggesting absence of significant publication bias. YETGIN T et al.
SMD was not substantially different from the initial overall estimate, suggesting the absence of significant publication bias (P=0.17; Figure 6 ).
Discussion
The current meta-analysis totaled 1,448 patients with CHD undergoing PCI or CABG who were randomized to RIC or control. RIC induced by transient limb ischemia was associated with a significant decrease of myocardial injury biomarkers in CABG (SMD -0.34, 95% CI: -0.59 to -0.08, P=0.009) and a statistically non-significant decrease in PCI (SMD -0.21, 95% CI: -0.66 to 0.24, P=0.36). This analysis represents the most comprehensive meta-analysis of RIC for patients undergoing PCI or CABG to date. The current data in trials examining RIC are limited to effects on surrogate endpoints of myocardial injury. In the present pooled analysis for PCI, we could not detect a significant reduction in myocardial injury biomarkers, although the direction of effect was protective. The most obvious reason for this finding is that there is no apparent IRI in the elective PCI studies. It must be appreciated that the contribution of IRI to myocardial injury varies with the clinical setting. For instance, myocardial injury encountered during primary PCI is a sum of IRI arising from abrupt reperfusion and ischemic cell death already caused by the preceding ischemic period. Whereas, in the setting of elective PCI, the myocardial injury sustained remains minimal due to absence of acute IRI and can be attributed to, for instance, distal embolization and side-branch occlusions. 27 Accordingly, the present analysis of the primary PCI trials showed the highest decrease in cardiac biomarkers in patients receiving RIC with no presence of heterogeneity. Indeed, the magnitude of myocardial injury is greater in this setting, and therefore the potential for benefit is amplified.
In the majority of the PCI trials, a unilateral stimulus was used to induce RIC. When we excluded the only trial in this setting using a bilateral stimulus of upper limb ischemia, 5 a significant pooled SMD in favor of RIC was produced with moderate heterogeneity among studies. Even though the present findings appear to favor unilateral induction of RIC, it is plausible that bilateral application of ischemia may represent a stronger stimulus. Therefore, the low-risk uncomplicated elective setting in which the study was conducted is a more likely explanation for the ineffectiveness of RIC in that study. 5 Importantly, the optimal type and algorithm of the conditioning stimulus in relation to the severity of the index ischemia remain elusive and require further investigation in both the experimental and clinical setting. 28-31 Importantly, however, we did not find a significant negative association between RIC and myocardial injury biomarkers in the elective PCI analysis.
Of note, patient selection is crucial when designing clinical trials of cardioprotection strategies as adjuncts to myocardial reperfusion in ST-elevation myocardial infarction patients. Current clinical evidence suggests that the patients who are most likely to benefit from a cardioprotective treatment strategy, given at the onset of myocardial reperfusion, are those with the larger areas at risk (usually an anterior infarct). In this regard, the sites of the infarcts were not reported by Rentoukas et al in their study, in which they demonstrated a non-significant reduction in peak TnI by RIC. 16 Presumably, in that group of patients, the contribution of lethal reperfusion injury was not significant, and thus, the use of RIC with myocardial reperfusion may not have been significantly beneficial. In addition, RIC was performed by applying three 4-min cycles of upper limb ischemia and reperfusion 10 min before the estimated time of first balloon inflation; a RIC protocol used for the first time in humans. Furthermore, the impact of clinical factors, such as age, comorbidities or co-medication on the effectiveness of RIC is unknown in the setting of PCI.
The setting of CABG provides a controlled scenario for acute myocardial IRI in which both cardioplegia and cross-clamp fibrillation (CCF) are routine techniques to protect the heart during cardiac arrest. The magnitude of myocardial injury sustained during CABG, however, is not only due to IRI arising from aortic clamping and declamping, but may also be attributed to, for instance, manual handling of the heart and coronary embolization. 32 In the pooled analysis for CABG, the use of RIC was associated with significant reductions of myocardial injury biomarkers compared to control above the additional forms of myocardial protection. This is critical when using RIC as a potential myocardial adjunct, especially given that the elevation of cardiac biomarkers included in the current analysis has been associated with adverse short-and long-term outcomes. 33- 35 Moreover, sensitivity analysis demonstrated the substantial stability of the present results. The use of inhalation anesthetics may also be expected to play a role in the myocardial protection in this setting. Volatile anesthetic agents such as isoflurane, enflurane and sevoflurane are known for their ability to precondition the heart (via activation of ATP-dependent K + channels) 36, 37 and, additionally, are capable of providing myocardial protection in CABG surgery. 38 In this view, we compared the studies using isoflurane, enflurane or sevoflurane as the anesthetic agent vs. a non-preconditioning anesthetic agent. Interestingly, we were unable to demonstrate additional benefit for RIC when the aforementioned preconditioning agents were used as the anesthetic regimen. When we restricted our meta-analysis to those studies using a non-preconditioning anesthetic agent, a highly significant decrease in myocardial injury biomarkers was found, with no presence of heterogeneity between trials. Although the exact significance of these findings is not clear, a possible explanation could be that both interventions act via similar pathways, reaching a plateau of protection.
When assessing the efficacy of a potential myocardial adjunct such as RIC, the measurement of serum cardiac biomarkers as surrogate endpoints has proven sufficient, as shown by the overall analysis for CABG. The optimum time point, however, for measurement of these biomarkers in order to assess RIC effectiveness remains unexplored. In this view, we compared the studies measuring biomarkers at 72 h vs. earlier time points. The decrease in myocardial injury biomarkers was far more prominent and significant when measured at 72 h as compared to earlier time points (P=0.29). This finding suggests that careful selection of the time point for biomarker measurement is imperative for optimizing efficacy assessment of RIC. For instance, in the first study of remote conditioning by transient ischemia in 4 patients undergoing elective CABG, RIC failed to affect CK-MB, which was measured only 5 min after declamping the aorta. 17 It is important to note that the study group in the included trials in the current analysis were medium-risk patients. Higher-risk patients tend to have greater myocardial injury; thus, will probably have a higher increase of myocardial injury biomarkers, in which the selection of earlier time points for measurement will presumably suffice. The majority of the CABG studies applied the 3×5-min remote conditioning protocol in which transient ischemia and reperfusion of the arm was induced by inflating a blood pressure cuff placed on the upper arm to 200 mmHg for 5 min and deflating the cuff for 5 min, repeated 3 times. The rationale for this approach originated during earlier studies demonstrating the attenuation of endothelial dysfunction in human volunteers and in patients with Remote Conditioning in PCI and CABG stable CHD. 39, 40 When we omitted the studies using a different stimulus from analysis, the SMD slightly shifted more in favor of RIC. Although this finding cannot remove the uncertainty about the optimal frequency and duration of the remote ischemic stimuli, it confirms that this protocol induces sufficient cardioprotection as measured by myocardial injury biomarkers. Similar to the setting of PCI, there are patients undergoing CABG who are more at risk of sustaining myocardial injury and thus, are potentially more likely to benefit from RIC. In this regard, the role of several potential confounding factors such as age, comorbidities and bypass and cross-clamp times are not clear. Importantly, however, it is clear from the current analysis that the presence of these factors did not prevent RIC from exerting a protective effect.
The present overall results are, in part, consistent with previous meta-analyses of RIPC in cardiovascular surgery, 41,42 but the trials included in those analyses examined the role of RIC in a variety of clinical scenarios ranging from congenital heart defect repair in children to open abdominal aortic aneurysm repair. The current analysis involving 1,448 patients focused exclusively on RIC in the setting of PCI and CABG. This allowed us to draw meaningful inferences on the effect of RIC in the specific respective ischemia-reperfusion scenario.
Study Limitations
There are several limitations to consider when interpreting the analysis. A first concern is the amount of heterogeneity observed in the overall analyses. Although we restricted analysis to studies with similar characteristics, considerable variation was observed, for example, in the myocardial protection mode in CABG. But when we restricted analysis to more similar studies, the statistical heterogeneity decreased or even became absent. In addition, we based our conclusions on the random effects model, an approach that accounts for some of the variance between studies. Second, we performed subgroup and sensitivity analyses. Given the (relatively) small number of studies in the analysis, this might be criticized. Investigation of the specific clinical differences between studies, however, is generally preferred rather than reliance on a statistical test for heterogeneity. 11 Moreover, by showing the main results including all studies followed by more restrictive analyses, we provided insight into the efficacy of RIC in the presence of one or more (potential) confounders and/or medical therapies. Third, the vast majority of the biomarkers in the included trials were measured using conventional (troponin) assays as opposed to high-sensitivity assays. High-sensitivity troponin assays allow detection of very minor damage to cardiac muscle. In this regard, these assays are yet to be fully evaluated in the setting of PCI and CABG and the impact of very low circulating concentrations of high-sensitivity troponins on clinical events remains to be determined. Nevertheless, the cardiac biomarkers included in the current analysis, measured using conventional assays, are highly sensitive and specific markers of myocardial injury and myonecrosis, and their elevation is closely related to adverse short-and long-term outcomes in PCI and CABG. [33] [34] [35] Finally, the clinical trials investigating RIC that have been performed to date are relatively small proof-of-concept trials using different protocols. In the absence of more adequately powered clinical trials, however, the currently available data need to be scrutinized to provide more insight into the efficacy of RIC in these settings.
Conclusions
Patients undergoing PCI or CABG receiving RIC with transient episodes of limb ischemia have lower biomarkers of myocardial injury compared to control. This effect, however, failed to reach statistical significance in the PCI group. Although the impact of several procedural details and cardiovascular risk factors on the effect of RIC remains unknown, the data generated so far in the setting of PCI and CABG are promising and RIC appears to be an important potential myocardial adjunct. Large randomized trials, however, are needed to establish the effect of RIC on clinical outcomes.
